120 related articles for article (PubMed ID: 27135302)
1. Childhood Neuroblastoma: Incidence and Survival in Argentina. Report from the National Pediatric Cancer Registry, ROHA Network 2000-2012.
Moreno F; Lopez Marti J; Palladino M; Lobos P; Gualtieri A; Cacciavillano W
Pediatr Blood Cancer; 2016 Aug; 63(8):1362-7. PubMed ID: 27135302
[TBL] [Abstract][Full Text] [Related]
2. Childhood osteosarcoma: Incidence and survival in Argentina. Report from the National Pediatric Cancer Registry, ROHA Network 2000-2013.
Moreno F; Cacciavillano W; Cipolla M; Coirini M; Streitenberger P; López Martí J; Palladino M; Morici M; Onoratelli M; Drago G; Schifino A; Cores M; Rose A; Jotomliansky J; Varel M; García Lombardi M
Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28409896
[TBL] [Abstract][Full Text] [Related]
3. A population-based study of retinoblastoma incidence and survival in Argentine children.
Moreno F; Sinaki B; Fandiño A; Dussel V; Orellana L; Chantada G
Pediatr Blood Cancer; 2014 Sep; 61(9):1610-5. PubMed ID: 24729462
[TBL] [Abstract][Full Text] [Related]
4. Childhood liver tumors in Argentina: Incidence trend and survival by treatment center. A report from the national pediatric cancer registry, ROHA network 2000-2015.
Moreno F; Rose A; Chaplin MA; Cipolla MC; García Lombardi M; Nana M; Cervio G; Halac E; Viso M; Ayarzabal V; Bosaleh A; Liberto D; Sarabia E; Rizzi A; Morici M; Streitenberger P; de Dávila MTG
Pediatr Blood Cancer; 2020 Nov; 67(11):e28583. PubMed ID: 32737960
[TBL] [Abstract][Full Text] [Related]
5. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
6. Neuroblastoma: changing incidence and survival in young people aged 0-24 years. A report from the North of England Young Persons' Malignant Disease Registry.
Cotterill SJ; Parker L; More L; Craft AW
Med Pediatr Oncol; 2001 Jan; 36(1):231-4. PubMed ID: 11464892
[TBL] [Abstract][Full Text] [Related]
7. Childhood cancer: incidence and early deaths in Argentina, 2000-2008.
Moreno F; Loria D; Abriata G; Terracini B;
Eur J Cancer; 2013 Jan; 49(2):465-73. PubMed ID: 22980725
[TBL] [Abstract][Full Text] [Related]
8. Neuroblastoma incidence and survival in European children (1978-1997): report from the Automated Childhood Cancer Information System project.
Spix C; Pastore G; Sankila R; Stiller CA; Steliarova-Foucher E
Eur J Cancer; 2006 Sep; 42(13):2081-91. PubMed ID: 16919772
[TBL] [Abstract][Full Text] [Related]
9. Childhood cancer in Argentina: Survival 2000-2007.
Moreno F; Dussel V; Orellana L;
Cancer Epidemiol; 2015 Aug; 39(4):505-10. PubMed ID: 25998586
[TBL] [Abstract][Full Text] [Related]
10. A population-based study of neuroblastoma incidence, survival, and mortality in North America.
Bernstein ML; Leclerc JM; Bunin G; Brisson L; Robison L; Shuster J; Byrne T; Gregory D; Hill G; Dougherty G
J Clin Oncol; 1992 Feb; 10(2):323-9. PubMed ID: 1732433
[TBL] [Abstract][Full Text] [Related]
11. Childhood cancer incidence and survival 2003-2005, Thailand: study from the Thai Pediatric Oncology Group.
Wiangnon S; Veerakul G; Nuchprayoon I; Seksarn P; Hongeng S; Krutvecho T; Sripaiboonkij N
Asian Pac J Cancer Prev; 2011; 12(9):2215-20. PubMed ID: 22296359
[TBL] [Abstract][Full Text] [Related]
12. Persisting inequalities in survival patterns of childhood neuroblastoma in Southern and Eastern Europe and the effect of socio-economic development compared with those of the US.
Panagopoulou P; Georgakis MK; Baka M; Moschovi M; Papadakis V; Polychronopoulou S; Kourti M; Hatzipantelis E; Stiakaki E; Dana H; Tragiannidis A; Bouka E; Antunes L; Bastos J; Coza D; Demetriou A; Agius D; Eser S; Gheorghiu R; Šekerija M; Trojanowski M; Žagar T; Zborovskaya A; Ryzhov A; Dessypris N; Morgenstern D; Petridou ET
Eur J Cancer; 2018 Jun; 96():44-53. PubMed ID: 29673989
[TBL] [Abstract][Full Text] [Related]
13. The incidence and mortality rates of neuroblastoma cases before and after the cessation of the mass screening program in Japan: A descriptive study.
Shinagawa T; Kitamura T; Katanoda K; Matsuda T; Ito Y; Sobue T
Int J Cancer; 2017 Feb; 140(3):618-625. PubMed ID: 27778323
[TBL] [Abstract][Full Text] [Related]
14. Effects of the Cessation of Mass Screening for Neuroblastoma at 6 Months of Age: A Population-Based Study in Osaka, Japan.
Ioka A; Inoue M; Yoneda A; Nakamura T; Hara J; Hashii Y; Sakata N; Yamato K; Tsukuma H; Kawa K
J Epidemiol; 2016; 26(4):179-84. PubMed ID: 26548355
[TBL] [Abstract][Full Text] [Related]
15. Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study.
George RE; London WB; Cohn SL; Maris JM; Kretschmar C; Diller L; Brodeur GM; Castleberry RP; Look AT
J Clin Oncol; 2005 Sep; 23(27):6466-73. PubMed ID: 16116152
[TBL] [Abstract][Full Text] [Related]
16. Neuroblastoma in adolescents: the Italian experience.
Conte M; Parodi S; De Bernardi B; Milanaccio C; Mazzocco K; Angelini P; Viscardi E; Di Cataldo A; Luksch R; Haupt R
Cancer; 2006 Mar; 106(6):1409-17. PubMed ID: 16475209
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological and some clinical characteristics of neuroblastoma in Mexican children (1996-2005).
Juárez-Ocaña S; Palma-Padilla V; González-Miranda G; Siordia-Reyes AG; López-Aguilar E; Aguilar-Martínez M; Mejía-Aranguré JM; Carreón-Cruz R; Rendón-Macías ME; Fajardo-Gutiérrez A
BMC Cancer; 2009 Aug; 9():266. PubMed ID: 19650918
[TBL] [Abstract][Full Text] [Related]
18. [Recent incidences and trends of childhood malignant solid tumors in Shanghai, 2002-2010].
Bao PP; Li K; Wu CX; Huang ZZ; Wang CF; Xiang YM; Peng P; Gong YM; Xiao XM; Zheng Y
Zhonghua Er Ke Za Zhi; 2013 Apr; 51(4):288-94. PubMed ID: 23927803
[TBL] [Abstract][Full Text] [Related]
19. Survival of high-risk pediatric neuroblastoma patients in a developing country.
Easton JC; Gomez S; Asdahl PH; Conner JM; Fynn AB; Ruiz C; Ojha RP
Pediatr Transplant; 2016 Sep; 20(6):825-30. PubMed ID: 27235336
[TBL] [Abstract][Full Text] [Related]
20. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK
J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
